With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence

Submitted by admin on October 10, 2018 - 9:00pm

Source:

Xconomy

News Tags:

Ligand Pharmaceuticals

Vernalis

M&A

Headline:

With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence

snippet:

Ligand Pharmaceuticals said Wednesday that its acquisition of U.K.-based biotech Vernalis has closed.

The $42.3 million deal netted the San Diego company eight partner programs and a 70-person R&D team in Cambridge, England, plus about $32 million in cash after deal costs.

Search form

You are here

With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence

With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence